Halozyme Therapeutics, Inc. (HALO) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 128.62 -0.33 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $128.95 | 52 Week High | $18.39 | |||
| Open | $128.29 | 52 Week Low | $6.96 | |||
| Day High | $131.36 | P/E | N/A | |||
| Day Low | $128.26 | EPS | $-0.58 | |||
| Volume | 1,495,541 | |||||
